시장보고서
상품코드
1441309

세계의 서방형 부형제 시장 규모, 점유율, 성장 분석, 제품 유형별, 투여 경로별, 기술별, 산업 예측(2023-2030년)

Global Sustained Release Excipients Market Size, Share, Growth Analysis, By Product type(Gelatin, Polymers), By Route of Administration(Oral, Intramuscular), By Technology(Targeted Delivery, Microencapsulation) - Industry Forecast 2023-2030

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 서방형 부형제 시장 규모는 2022년 12억 6,000만 달러로 평가되었습니다. 2023년 13억 7,000만 달러에서 2031년에는 26억 달러에 달하고, 예측 기간(2024-2031년) 동안 8.4%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계 서방형 부형제 시장은 꾸준히 성장하고 있으며, 향후에도 지속적으로 확대될 것으로 예상됩니다. 서방형 부형제는 유효 성분을 장기간에 걸쳐 점진적으로 방출하도록 설계된 제제의 핵심 성분으로, 환자의 순응도와 치료 결과를 개선하는 데 중요한 역할을 합니다. 이 시장은 만성 질환의 확산, 혁신적인 약물 전달 시스템에 대한 수요 증가, 의약품 연구 및 개발에 대한 투자 증가 등 여러 요인에 의해 주도되고 있습니다. 또한 인구 고령화와 이에 따른 장시간 작용하는 약물에 대한 수요가 급증하면서 시장 성장을 더욱 촉진하고 있습니다. 서방형 제제에는 폴리머, 지질, 하이드로겔 등 다양한 부형제가 사용됩니다. 에틸셀룰로오스, 하이드록시프로파일메틸셀룰로오스(HPMC), 폴리(젖산-코-글리콜산)(PLGA)와 같은 폴리머는 생체적합성, 방출 조절 특성, 제형 다양성 등으로 인해 특히 주목받고 있습니다.

목차

주요 요약

  • 시장 개요
  • 번영과 쇠퇴

조사 방법

  • 정보 조달
  • 2차/1차 정보원
  • 시장 규모 추정
  • 시장 전제조건과 제한

상위 시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공 요인
  • 경쟁 정도

시장 역학과 전망

  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제
  • 규제 상황
  • Porter의 Five Forces 분석
  • 향후 혼란에 관한 특별 인사이트

세계의 서방형 부형제 시장 : 제품 유형별

  • 시장 개요
  • 젤라틴
  • 폴리머
  • 미네랄
  • 슈가
  • 기타

세계의 서방형 부형제 시장 : 투여 경로별

  • 시장 개요
  • 경구
  • 근육내
  • 피하
  • 경피
  • 정맥내
  • 기타 투여 경로

세계의 서방형 부형제 시장 : 기술별

  • 시장 개요
  • Targeted Delivery
  • Microencapsulation
  • Wurster Technique
  • 기타 기술

세계의 서방형 부형제 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 구도

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2021년)
  • 주요 시장 기업이 채택한 전략
  • 주요 성공 전략
  • 시장에서의 최근 활동
  • 주요 기업의 시장 점유율(2021년)

주요 기업 개요

  • Allergan PLC(아일랜드)
  • AstraZeneca(영국)
  • GlaxoSmithKline PLC(영국)
  • Mayne Pharma Group Limited(호주)
  • Mylan NV(미국)
  • Novartis AG(스위스)
  • Pfizer Inc.(미국)
  • Salix Pharmaceuticals(미국)
  • Sun Pharmaceutical Industries Ltd(인도)
  • Roche Holdings AG(스위스)
  • Sanofi(프랑스)
  • Johnson & Johnson(미국)
  • Eli Lilly and Company(미국)
  • Merck & Co., Inc.(미국)
  • Teva Pharmaceutical Industries Ltd(이스라엘)
  • AbbVie Inc.(미국)
  • Bristol-Myers Squibb(미국)
  • Gilead Sciences, Inc.(미국)
  • Bayer AG(독일)
  • Takeda Pharmaceutical Company Limited(일본)
LSH 24.04.11

Global Sustained Release Excipients Market size was valued at USD 1.26 billion in 2022 and is poised to grow from USD 1.37 billion in 2023 to USD 2.60 billion by 2031, growing at a CAGR of 8.4% in the forecast period (2024-2031).

The global sustained release excipients market was experiencing steady growth and is expected to continue expanding in the coming years. Sustained release excipients are crucial components in drug formulations designed to release active ingredients gradually over an extended period, thereby improving patient compliance and therapeutic outcomes. The market is driven by several factors, including the rising prevalence of chronic diseases, increasing demand for innovative drug delivery systems, and growing investment in pharmaceutical research and development. Additionally, the aging population and the subsequent surge in demand for long-acting medications further fuel market growth. Various excipients are utilized in sustained release formulations, including polymers, lipids, and hydrogels, among others. Polymers such as ethylcellulose, hydroxypropyl methylcellulose (HPMC), and poly (lactic-co-glycolic acid) (PLGA) are particularly prominent due to their biocompatibility, controlled release properties, and versatility in formulation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sustained Release Excipients Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sustained Release Excipients Market Segmental Analysis

Based on product type the market is segmented as Gelatin, Polymers, Minerals, Sugars, and Others. On the basis of route of administration the market is segmented as Oral, Intramuscular, Subcutaneous, Transdermal, Intravenous, and Other Routes of Administration. Based on technology, it is segregated into Targeted Delivery, Microencapsulation, Wurster Technique, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Sustained Release Excipients Market

One key market driver propelling the growth of the sustained release excipients market is the rising geriatric population worldwide. With aging populations, there is a higher incidence of chronic diseases such as cardiovascular disorders, diabetes, and neurological conditions, necessitating long-term medication regimens. Sustained release formulations offer advantages in terms of improved patient compliance, reduced side effects, and enhanced therapeutic outcomes by maintaining consistent drug levels in the body over an extended period. Consequently, pharmaceutical manufacturers are increasingly incorporating sustained release excipients into their formulations to cater to the needs of the aging population, thereby driving market expansion.

Restraints in the Global Sustained Release Excipients Market

However, despite the promising growth prospects, the sustained release excipients market faces certain restraints that may hinder its growth trajectory. One notable challenge is the stringent regulatory requirements governing the approval and commercialization of sustained release formulations. Regulatory agencies impose rigorous standards for the safety, efficacy, and quality of pharmaceutical products, including those utilizing sustained release technologies. Meeting these regulatory guidelines demands substantial investments in research, development, and manufacturing capabilities, which can pose barriers to entry for smaller players and startups. Moreover, delays in regulatory approvals can prolong the time to market, impacting product launch timelines and revenue generation potential for companies operating in this space.

Market Trends of the Global Sustained Release Excipients Market

In terms of trends, there is a growing emphasis on the development of innovative sustained release excipients to address evolving market needs and enhance product performance. Manufacturers are investing in advanced formulation technologies and excipient materials to achieve optimized drug release profiles, improved bioavailability, and enhanced stability of pharmaceutical formulations. Additionally, there is increasing adoption of multifunctional excipients capable of providing additional functionalities such as taste masking, moisture protection, and modified release kinetics. Furthermore, strategic collaborations and partnerships between pharmaceutical companies and excipient suppliers are on the rise to leverage combined expertise and resources for product development and commercialization, thereby driving innovation and market growth in the sustained release excipients segment.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Sustained Release Excipients Market by Product type

  • Market Overview
  • Gelatin
  • Polymers
  • Minerals
  • Sugars
  • and Others

Global Sustained Release Excipients Market by Route of Administration

  • Market Overview
  • Oral
  • Intramuscular
  • Subcutaneous
  • Transdermal
  • Intravenous
  • and Other Routes of Administration

Global Sustained Release Excipients Market by Technology

  • Market Overview
  • Targeted Delivery
  • Microencapsulation
  • Wurster Technique
  • and Other Technologies

Global Sustained Release Excipients Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Allergan PLC (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mayne Pharma Group Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylan NV (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Salix Pharmaceuticals (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Ltd (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holdings AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AbbVie Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bristol-Myers Squibb (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gilead Sciences, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takeda Pharmaceutical Company Limited (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제